XETRA - Delayed Quote
EUR
Novo Nordisk A/S (NOV.DE)
35.71
+0.94
(+2.70%)
At close: October 30 at 5:35:53 PM GMT+1
Earnings Trends
Earnings Per Share
No Earnings Per Share available for this ticker
Revenue vs. Earnings
Q2 FY26
Revenue
78.49B
Earnings
20.99B
Profit Margin
26.74%
Q3
FY25
Q4
FY25
Q1
FY26
Q2
FY26
0
20B
40B
60B
30.0%
40.0%
50.0%
60.0%
Revenue Estimate
| Currency in DKK
|
Current Qtr. (Sep 2026)
|
Next Qtr. (Dec 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
No. of Analysts
|
13 | 9 | 27 | 25 |
|
Avg. Estimate
|
73.79B | 76.23B | 303.54B | 307.63B |
|
Low Estimate
|
71.19B | 72.18B | 280.93B | 285.27B |
|
High Estimate
|
78.49B | 78.76B | 334.98B | 343.47B |
|
Year Ago Sales
|
74.98B | 79.14B | 309.06B | 303.54B |
|
Sales Growth (year/est)
|
-1.58% | -3.69% | -1.79% | 1.35% |
Earnings Estimate
| Currency in USD
|
Current Qtr. (Sep 2026)
|
Next Qtr. (Dec 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
No. of Analysts
|
-- | -- | -- | -- |
|
Avg. Estimate
|
-- | -- | -- | -- |
|
Low Estimate
|
-- | -- | -- | -- |
|
High Estimate
|
-- | -- | -- | -- |
|
Year Ago EPS
|
-- | -- | -- | -- |
EPS Trend
| Currency in USD
|
Current Qtr. (Sep 2026)
|
Next Qtr. (Dec 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
Current Estimate
|
-- | -- | -- | -- |
|
7 Days Ago
|
-- | -- | -- | -- |
|
30 Days Ago
|
-- | -- | -- | -- |
|
60 Days Ago
|
-- | -- | -- | -- |
|
90 Days Ago
|
-- | -- | -- | -- |
EPS Revisions
| Currency in USD
|
Current Qtr. (Sep 2026)
|
Next Qtr. (Dec 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
Up Last 7 Days
|
-- | -- | -- | -- |
|
Up Last 30 Days
|
-- | -- | -- | -- |
|
Down Last 7 Days
|
-- | -- | -- | -- |
|
Down Last 30 Days
|
-- | -- | -- | -- |
Growth Estimates
| Symbol | Current Qtr. | Next Qtr. | Current Year | Next Year |
|---|---|---|---|---|
|
NOV.DE
|
-- | -- | -- | -- |
|
S&P 500
|
26.99% | 26.80% | 32.87% | 16.85% |
